A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma

被引：0
|
作者：
Zhen, Changqing [1 ]
Ding, Mei [1 ]
Lu, Kang [1 ]
Ge, Xueling [1 ]
Chen, Na
Fang, Xiaosheng [1 ]
Sui, Xiaohui [1 ]
Jiang Yujie [1 ]
Liu, Xin [1 ]
Li, Ying [1 ]
Wang, Xianghua [1 ]
Li, Ying [1 ]
Zhang, Lingyan [1 ]
Xu, Hongzhi [1 ]
Fan, Juan [1 ]
Wang, Xin [1 ]
机构：
[1] Shandong Univ, Dept Hematol, Shandong Prov Hosp, Jinan, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5323
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of PEG-rhG-CSF in primary and secondary prevention of chemotherapy-induced neutropenia.
    Zhu, Jun
    Li, Huiping
    Fan, Zhengfu
    Gao, Yunong
    Tu, Meifeng
    Shao, Bin
    Gao, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] A prospective, randomized, controlled clinical trial comparing different PEG-rhG-CSF administration times to treat chemotherapy-induced neutropenia and febrile neutropenia in early breast cancer
    Zha, Xiaoming
    Wang, Jue
    Xu, Yinggang
    He, Jinzhi
    Wang, Ye
    Zhang, Weiwei
    Wan, Xinyu
    Shi, Wenjie
    CANCER RESEARCH, 2024, 84 (09)
  • [3] PEG-rhG-CSF for prophylaxis of neutropenia after chemotherapy in patients with non-small cell lung cancer: A multicenter, prospective, randomized study
    Sun, Xu-Sheng
    Wang, Zhe
    Ren, Shu-Hua
    Zhang, He-Lin
    Liu, Li-Jun
    Du, Hong-Bo
    Liu, Xiao-Wei
    Liu, Jun-Feng
    THORACIC CANCER, 2022, 13 (17) : 2429 - 2435
  • [4] Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
    Yantao Jiang
    Ju Zhang
    Jianxin Zhong
    Hao Liao
    Jiayang Zhang
    Yaxin Liu
    Yuehua Liang
    Huiping Li
    BMC Cancer, 23
  • [5] Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
    Jiang, Yantao
    Zhang, Ju
    Zhong, Jianxin
    Liao, Hao
    Zhang, Jiayang
    Liu, Yaxin
    Liang, Yuehua
    Li, Huiping
    BMC CANCER, 2023, 23 (01)
  • [6] Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study)
    Wolff, Thomas
    Schulz, Holger
    Losem, Christoph
    Reichert, Dietmar
    Hurtz, Hans-Juergen
    Sandner, Reiner
    Harde, Johanna
    Grebhardt, Sina
    Potthoff, Karin
    Mueller, Udo
    Fietz, Thomas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (02) : 174 - 181
  • [7] Chronic Comorbidities and Chemotherapy-Induced Febrile Neutropenia in Patients with Non-Hodgkin Lymphoma
    Chao, Chun
    Page, John H.
    Rodriguez, Roberto
    Yang, Su-Jau
    Huynh, Julie
    Chia, Victoria M.
    BLOOD, 2012, 120 (21)
  • [8] A prospective, randomized clinical trial of emergency treatment of chemotherapy-induced neutropenia and febrile neutropenia by pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF)
    Huang, Xiaofeng
    Li, Shuo
    Shi, Wenjie
    Wang, Ye
    Wan, Xinyu
    He, Jinzhi
    Xu, Yinggang
    Zhang, Weiwei
    Shi, Xiaoqing
    Chen, Rui
    Xu, Lu
    Zha, Xiaoming
    Wang, Jue
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 372 - 379
  • [9] Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP
    Shikata, Hisaharu
    Yakushijin, Yoshihiro
    Yamanouchi, Jun
    Azuma, Taichi
    Yasukawa, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 178 - 185
  • [10] Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP
    Hisaharu Shikata
    Yoshihiro Yakushijin
    Jun Yamanouchi
    Taichi Azuma
    Masaki Yasukawa
    International Journal of Clinical Oncology, 2014, 19 : 178 - 185
12345